Report Detail
Global Crysvita Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4655201 |
- 05 December, 2025 |
- Global |
- 85 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Crysvita Injection market size was valued at US$ 74.2 million in 2024 and is forecast to a readjusted size of USD 92.4 million by 2031 with a CAGR of 3.2% during review period.
X-linked hypophosphatemia, or XLH, is a hereditary skeletal disease triggered by excess production of the hormone fibroblast growth factor 23. FGF23 causes phosphate urinary excretion and hinders patients" ability to produce vitamin D. CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
Brosumab (burosumab, trade name Crysvita) is a recombinant fully humanized monoclonal IgG1 antibody targeting fibroblast growth factor 23 (FGF23) jointly developed by Ultragenyx Pharmaceutical and Kyowa Hakko Kirin. In February 2018, the drug was conditionally approved by the European Union for the treatment of X-linked hypophosphatemia (XLH) in children and adults aged 1 and above, becoming the world"s first XLH treatment drug, and it was approved by the FDA in April of the same year indications. In September of the following year, the drug was approved by the FDA to expand the indication population to infants as young as 6 months old. FGF23 is a bone-derived hormone that regulates the metabolism of phosphorus and vitamin D. It can block the reabsorption of phosphate by the kidney and inhibit the absorption of vitamin D-dependent phosphate, resulting in a significant decrease in the level of phosphate in the blood. It is XLH main culprit. XLH is a rare genetic disorder and the most common form of hypophosphatemic rickets, affecting 1 in 20,000 people. XLH is carried on the X chromosome, and while nearly all X-linked disorders are recessive, XLH is one of the few that is inherited in a dominant manner.
This report is a detailed and comprehensive analysis for global Crysvita Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Crysvita Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Crysvita Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Crysvita Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Crysvita Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Crysvita Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Crysvita Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kyowa Kirin, Ultragenyx Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Crysvita Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10 mg/mL
20 mg/mL
30 mg/mL
Market segment by Application
Children
Adults
Major players covered
Kyowa Kirin
Ultragenyx Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crysvita Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Crysvita Injection, with price, sales quantity, revenue, and global market share of Crysvita Injection from 2020 to 2025.
Chapter 3, the Crysvita Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crysvita Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Crysvita Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Crysvita Injection.
Chapter 14 and 15, to describe Crysvita Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Crysvita Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 10 mg/mL
- 1.3.3 20 mg/mL
- 1.3.4 30 mg/mL
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Crysvita Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Children
- 1.4.3 Adults
- 1.5 Global Crysvita Injection Market Size & Forecast
- 1.5.1 Global Crysvita Injection Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Crysvita Injection Sales Quantity (2020-2031)
- 1.5.3 Global Crysvita Injection Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Kyowa Kirin
- 2.1.1 Kyowa Kirin Details
- 2.1.2 Kyowa Kirin Major Business
- 2.1.3 Kyowa Kirin Crysvita Injection Product and Services
- 2.1.4 Kyowa Kirin Crysvita Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Kyowa Kirin Recent Developments/Updates
- 2.2 Ultragenyx Pharmaceutical
- 2.2.1 Ultragenyx Pharmaceutical Details
- 2.2.2 Ultragenyx Pharmaceutical Major Business
- 2.2.3 Ultragenyx Pharmaceutical Crysvita Injection Product and Services
- 2.2.4 Ultragenyx Pharmaceutical Crysvita Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Ultragenyx Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Crysvita Injection by Manufacturer
- 3.1 Global Crysvita Injection Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Crysvita Injection Revenue by Manufacturer (2020-2025)
- 3.3 Global Crysvita Injection Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Crysvita Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Crysvita Injection Manufacturer Market Share in 2024
- 3.4.3 Top 6 Crysvita Injection Manufacturer Market Share in 2024
- 3.5 Crysvita Injection Market: Overall Company Footprint Analysis
- 3.5.1 Crysvita Injection Market: Region Footprint
- 3.5.2 Crysvita Injection Market: Company Product Type Footprint
- 3.5.3 Crysvita Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Crysvita Injection Market Size by Region
- 4.1.1 Global Crysvita Injection Sales Quantity by Region (2020-2031)
- 4.1.2 Global Crysvita Injection Consumption Value by Region (2020-2031)
- 4.1.3 Global Crysvita Injection Average Price by Region (2020-2031)
- 4.2 North America Crysvita Injection Consumption Value (2020-2031)
- 4.3 Europe Crysvita Injection Consumption Value (2020-2031)
- 4.4 Asia-Pacific Crysvita Injection Consumption Value (2020-2031)
- 4.5 South America Crysvita Injection Consumption Value (2020-2031)
- 4.6 Middle East & Africa Crysvita Injection Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Crysvita Injection Sales Quantity by Type (2020-2031)
- 5.2 Global Crysvita Injection Consumption Value by Type (2020-2031)
- 5.3 Global Crysvita Injection Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Crysvita Injection Sales Quantity by Application (2020-2031)
- 6.2 Global Crysvita Injection Consumption Value by Application (2020-2031)
- 6.3 Global Crysvita Injection Average Price by Application (2020-2031)
7 North America
- 7.1 North America Crysvita Injection Sales Quantity by Type (2020-2031)
- 7.2 North America Crysvita Injection Sales Quantity by Application (2020-2031)
- 7.3 North America Crysvita Injection Market Size by Country
- 7.3.1 North America Crysvita Injection Sales Quantity by Country (2020-2031)
- 7.3.2 North America Crysvita Injection Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Crysvita Injection Sales Quantity by Type (2020-2031)
- 8.2 Europe Crysvita Injection Sales Quantity by Application (2020-2031)
- 8.3 Europe Crysvita Injection Market Size by Country
- 8.3.1 Europe Crysvita Injection Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Crysvita Injection Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Crysvita Injection Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Crysvita Injection Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Crysvita Injection Market Size by Region
- 9.3.1 Asia-Pacific Crysvita Injection Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Crysvita Injection Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Crysvita Injection Sales Quantity by Type (2020-2031)
- 10.2 South America Crysvita Injection Sales Quantity by Application (2020-2031)
- 10.3 South America Crysvita Injection Market Size by Country
- 10.3.1 South America Crysvita Injection Sales Quantity by Country (2020-2031)
- 10.3.2 South America Crysvita Injection Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Crysvita Injection Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Crysvita Injection Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Crysvita Injection Market Size by Country
- 11.3.1 Middle East & Africa Crysvita Injection Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Crysvita Injection Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Crysvita Injection Market Drivers
- 12.2 Crysvita Injection Market Restraints
- 12.3 Crysvita Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Crysvita Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Crysvita Injection
- 13.3 Crysvita Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Crysvita Injection Typical Distributors
- 14.3 Crysvita Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Crysvita Injection. Industry analysis & Market Report on Crysvita Injection is a syndicated market report, published as Global Crysvita Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Crysvita Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
